Add Yahoo as a preferred source to see more of our stories on Google. Early signs of functional improvement were recorded Opus Genetics has reported early findings from its ongoing Phase I/II clinical ...
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results